It was reported that a patient underwent an atrial flutter (afl) ablation procedure with a webster duo-decapolar catheter which was webster caught in a 6fr sheath requiring a wire and snare for removal.Atrial flutter (afl) ablation was performed using a webster duo-decapolar catheter to treat atrial flutter.Because it was difficult to secure the peripheral venous tract, a 6 fr sheath was inserted via the right common femoral vein before general anesthesia.When the webster duo-decapolar catheter was inserted into the patient's body, it was caught in a 6fr sheath (other manufacture's product).When attempting to remove the webster duo-decapolar catheter, it broke and could not be removed.The webster duo-decapolar catheter was removed using a wire (other manufacture's product) and a snare (other manufacture's product).The procedure was successfully completed using another catheter (product name was unknown).There was no health hazard occurred.
|
Device investigation details: information received indicates that the device is not available for return, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.A manufacturing record evaluation (mre) cannot be conducted because no lot number was provided by the customer.If the product or product id numbers are received at a later date, the investigation will be updated as applicable.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.D4.Catalog: unk_webster bipolar - deflectable e1.Initial reporter phone: (b)(6) if additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|